Leading global contract research organizations based on revenue 2021
In 2021, the leading contract research organizations worldwide included Laboratory Corporation of America Holdings, ThermoFisher Scientific, and IQVIA. The top company, Laboratory Corporation of America Holdings had more than 16 billion U.S. dollars in revenue during that year. Comparatively, the second company ThermoFisher Scientific, which recently acquired Pharmaceutical Product Development (PPD), generated nearly 15 billion U.S. dollars in revenue through its clinical research business.
Contract research organizations
Contract research organizations (CROs) are companies that are contracted by larger pharmaceutical companies to manage select aspects of clinical trials. Today, CROs are essential for pharmaceutical research and development. Pharmaceutical companies are spending more money than ever on research and development and there is no indication that spending will decrease in the future. Evidence suggests that CROs will become even more valuable. The clinical CRO market is expected to increase over 60 billion U.S. dollars by 2024.
Pharmaceutical research and development
Globally, Roche and Johnson & Johnson will be the top pharmaceutical companies based on their projected research and development spending. There are regional differences in research and development among pharmaceutical companies. Of all pharmaceutical companies globally those based in the U.S. developed the most new chemical or biological entities between 2017 and 2021.
Contract research organizations
Contract research organizations (CROs) are companies that are contracted by larger pharmaceutical companies to manage select aspects of clinical trials. Today, CROs are essential for pharmaceutical research and development. Pharmaceutical companies are spending more money than ever on research and development and there is no indication that spending will decrease in the future. Evidence suggests that CROs will become even more valuable. The clinical CRO market is expected to increase over 60 billion U.S. dollars by 2024.
Pharmaceutical research and development
Globally, Roche and Johnson & Johnson will be the top pharmaceutical companies based on their projected research and development spending. There are regional differences in research and development among pharmaceutical companies. Of all pharmaceutical companies globally those based in the U.S. developed the most new chemical or biological entities between 2017 and 2021.
